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Abstract 
Background Clinical decision-making regarding diagnosis and management largely depends on 
comparison with healthy or ‘normal’ values. Physiotherapists and researchers therefore need access 
to robust patient-centred outcome measures and appropriate reference values. However there is a 
lack of high-quality reference data for many clinical measures. The aim of the 1000 Norms Project is 
to generate a freely accessible database of musculoskeletal and neurological reference values 
representative of the healthy population across the lifespan. 
Methods/design In 2012 the 1000 Norms Project Consortium defined the concept of ‘normal’, 
established a sampling strategy and selected measures based on clinical significance, psychometric 
properties and the need for reference data. Musculoskeletal and neurological items tapping the 
constructs of dexterity, balance, ambulation, joint range of motion, strength and power, endurance 
and motor planning will be collected in this cross-sectional study. Standardised questionnaires will 
evaluate quality of life, physical activity, and musculoskeletal health. Saliva DNA will be analysed for 
the ACTN3 genotype (‘gene for speed’). A volunteer cohort of 1000 participants aged 3 to 100 years 
will be recruited according to a set of self-reported health criteria. Descriptive statistics will be 
generated, creating tables of mean values and standard deviations stratified for age and gender. 
Quantile regression equations will be used to generate age charts and age-specific centile values.  
Discussion This project will be a powerful resource to assist physiotherapists and clinicians across all 
areas of healthcare to diagnose pathology, track disease progression and evaluate treatment 
response. This reference dataset will also contribute to the development of robust patient-centred 
clinical trial outcome measures. 
 
Introduction 
Evidenced-based practice is currently focused on patient-centred outcomes [1]. The ability of 
outcome measures to inform clinical decision-making is dependent on the development of reference 
values representative of the healthy population. In physiotherapy and other fields of healthcare, an 
understanding of physical performance and the range of normal variation is essential, as decisions 
regarding diagnosis, management and prevention of musculoskeletal and neurological disorders are 
frequently based on comparison with healthy or ‘normal’ values. To prescribe interventions for 
improving quality of care, we must first establish a set of clinically relevant measures [2,3]. To 
evaluate the impact of physical therapies and to communicate clearly and succinctly with colleagues, 
valid and reliable data are required [4]. At the patient level, a normative reference database 
provides important information regarding diagnosis, symptom risk and status change in response to 
treatment, allowing their progress to be more closely assessed and treatment effectiveness more 
clearly determined [5]. Greater understanding of physical performance and normal variation in the 
healthy population and identifying age-related changes in musculoskeletal and neurological function 
will assist outcome measure development for clinical trials. 
Currently limited comprehensive datasets exist detailing the range of normal variation in healthy 
individuals. Previous studies establishing reference values have typically comprised a limited number 
of measures and have frequently involved young, disease-free adults, reducing the applicability of 
the reference data to the wider population [6]. Furthermore, reference values published in 
restricted access journals can render such data inaccessible to many researchers and most clinicians. 
Reference value datasets do exist for a select range of measures, such as grip strength [7], range of 
motion [8], strength [9], and gait [10], however there is no single resource containing reference 
values for males and females across the lifespan for musculoskeletal and physical performance 
measures. Therefore, there is an immediate need for reference values that are representative of the 
healthy normal population and presented in a manner that can be accessed by all [11]. This single 
resource will be a central point of reference for physiotherapists, clinical researchers and other 
health professionals to access reference data, including details pertaining to reliability, validity and 
assessment protocols. The 1000 Norms Project reference dataset will stimulate high impact research 
activity, enabling robust evaluations with sensitive outcome measures, analysis of clinically relevant 
subgroups and a greater understanding of the interactions and associations between different 
musculoskeletal and neurological measures of health. The need for standardised measures has also 
been identified by the National Institutes of Health (NIH) who developed the NIH Toolbox to 
advocate for standard assessment of neurological and behavioural function [12]. The NIH Toolbox is 
a set of standard measures within the domains of cognition, motor function, sensory function and 
emotional health. The 1000 Norms Project will contribute to this international focus on accurate 
outcomes by producing a large reference dataset of standardised musculoskeletal and neurological 
measures collected in a cohort of healthy individuals across the lifespan. 
Research focusing on ageing and lifestyle has demonstrated that habitual physical activity interacts 
with ageing and has the capacity to modulate musculoskeletal health and functional performance 
[13]. The influence of epigenetic factors, notably physical activity habits on muscle phenotypes in the 
elderly, suggests that genotype is possibly the strongest candidate to explain variance among muscle 
phenotypes [14]. Alpha-actinin-3 (ACTN3) has been identified as one of many genes contributing to 
genetic variation in muscle performance and adaptation to exercise. ACTN3 has been shown to have 
a beneficial effect on the function of skeletal muscle in generating muscle force [15,16]. Several 
cross-sectional studies indicate an association between athletic performance and ACTN3 genotype 
[16–18], however participants in these studies were highly trained athletes and may not be 
representative of the general population. Hagberg et al. [19] states that whilst there is evidence that 
ACTN3 acts as a contributor to muscle trait variation, the importance in the untrained population 
remains unclear. Further studies are needed to establish the influence of ACTN3 on functional 
abilities in elderly populations, for instance, to target individuals who may be more susceptible to 
the effects of sarcopenia and require specific interventions [20,21]. The 1000 Norms Project will 
contribute to the understanding of the genetic contribution to human phenotype by investigating 
the association of ACTN3 genotype with the physical performance items related to strength and 
power in individuals across the lifespan. 
The primary aim of the 1000 Norms Project is to generate a wide ranging database of 
musculoskeletal and neurological reference values in a cohort of 1000 healthy individuals aged 3 to 
100 years. A secondary aim is to develop predictive equations adjusted for factors such as age and 
gender for each individual measure. 
 
Methods 
Overview of the study design 
In 2012, the 1000 Norms Project Consortium, an interdisciplinary multi-institutional collaboration of 
researchers, clinicians and higher degree students, designed the 1000 Norms Project over a four 
stage process which included: (1) the establishment of working parties, (2) a comprehensive review 
of the definition of ‘normal’, (3) identifying viable sampling and recruitment strategies, and (4) 
selection of clinically relevant patient-centred musculoskeletal and neurological items to be 
collected in the Project. Expert physiotherapists, scientists and clinical researchers were invited to 
join the 1000 Norms Project Consortium to contribute or recommend items for inclusion in the 
Project. Items were considered for inclusion if there was an absence of high quality reference data 
across the lifespan, if they had acceptable psychometric properties and were feasible in terms of 
time and equipment. Items had to be measurable across all ages, with low ceiling and floor effects, 
and had minimal risk of injury to participants and examiners. For the selection criteria of items 
considered for inclusion in the 1000 Norms Project, see online supplementary Appendix A. A flow 
chart summarising the selection process is shown in Fig. 1. Items aligned with current research foci, 
such as the performance based tests recommended by the Osteoarthritis Research Society 
International (OARSI) [22] and the NIH Motor Assessment [23] were also considered. 
 Fig 1. 
The 1000 Norms Project is a cross-sectional study which has received institutional ethics approval. 
The descriptive nature of the 1000 Norms Project as well as the number and age range of 
participants makes it ideally suited to a cross-sectional study design. There is no loss to follow up 
and this design allows researchers to investigate associations between a wide range of outcome 
variables. Participants will also be invited to express their interest in participating in future research 
involving the 1000 Norms Project, creating the possibility of a longitudinal cohort investigation. 
Consent will be obtained from all participants aged 18 years and over, and from a parent or guardian 
for all participants aged between 3 and 17 years. Separate consent will be obtained for the collection 
of saliva DNA. 
 
Recruitment strategies 
The 1000 Norms Project Consortium endeavoured to identify a sample of individuals living in 
Australia who are representative of the healthy ‘normal’ population across the lifespan. Previous 
studies involving large reference cohorts were evaluated for recruitment strategies, sampling 
methods, response rates and feasibility [8,24–26]. Stratified random sampling options were 
extensively investigated such as accessing the electoral roll and Medicare government databases. In 
Australia, sampling and recruitment strategies have altered greatly with the implementation of the 
Privacy Act 1988 and its associated amendment, the Privacy Amendment (Enhancing Primary 
Protection) Act 2012, the Personal Information Protection Act 1998 (NSW) and the Health Records 
and Information Privacy Act 2002 (NSW), preventing access to role based data for research 
purposes. The possibility of employing external companies to randomly contact individuals and 
screening for participation in the 1000 Norms Project was also explored. However, the Australia 
Communications and Media Authority states that the ‘mobile phone only’ population in Australia in 
2012 was 20%, rendering a truly random sample via landline contact less likely. As such, the 1000 
Norms Project Consortium concluded that a highly structured convenience sampling strategy would 
be used. 
Local recruitment of participants in the Sydney metropolitan area surrounding the Faculty of Health 
Sciences, The University of Sydney Lidcombe, New South Wales, Australia, will be targeted since it 
demonstrates similar socioeconomic representation of the greater Australian population according 
to the ABS Socio-Economic Indexes For Areas (SEIFA) [27]. Information regarding ethnicity and 
socioeconomic status, including levels of education and occupation, will be collected to further 
define the representativeness of the sample for external validity. Utilising a variety of advertising 
mediums, initial contact will be made with potential participants via: council, community and 
religious groups, aged care independent living facilities, public and private schools, government 
subsidised and private childcare centres, sporting clubs, local area housing and shopping centres, 
social media (Facebook and Twitter), as well as tertiary and vocational education institutions. A 
variety of print, radio and television media will also be conducted. The recruitment and advertising 
campaign will be delivered in promotional waves every two months until data collection is complete. 
Potential participants will be invited to contact the 1000 Norms Project coordinators (M.J.M. and 
J.N.B) for a telephone interview to assess eligibility and schedule an appointment for assessment. 
Eligible participants will be sent a detailed information package and a confirmation phone call two 




Table 1 Age distribution of participants.  
Age Group (year) Number of participants 
3 to 9 140 (20 per age year) 
10 to 19 160 (16 per age year) 
20 to 29 100 
30 to 39 100 
40 to 49 100 
50 to 59 100 
60 to 69 100 
70 to 79 100 
80 to 100 100 
 
The highly structured convenient sampling approach was devised by the 1000 Norms Project 
Consortium as it was the most feasible and efficient way to recruit participants given the nature of 
the study (i.e. large scale, participants across the lifespan, location of the study). The extensive range 
of recruitment techniques utilised to enlist potential participants from diverse socioeconomic and 
cultural backgrounds, as well as people from a broad range of physical fitness and sport involvement 
will minimise potential sources of sampling bias [28] and volunteer bias [29]. Information bias [30], 
which includes systematic distortions or errors when collecting and measuring an outcome, has been 
dealt with through careful planning and study design, including rigorous training, piloting and 
reliability testing prior to commencement. 
 
Participants 
The 1000 Norms Project will recruit 1000 participants aged 3 to 100 years. Age will be based on the 
last birthday. Equal numbers of males and females will be recruited to represent the Australian 
population and participants will be stratified for age as shown in Table 1. Oversampling of 
participants in the younger age groups (3 to 19 years) has been planned to reflect the rapid changes 
associated with maturation and growth during this period. 
To ensure a cohort representative of the healthy ‘normal’ population, a set of self-assessment 
inclusion criteria to classify health status have been determined according to the World Health 
Organisation [31] and Rattan [32] (definitions). The 1000 Norms Project defines health as a state of 
adequate independence in daily life and describes the ability of individuals to adapt to the expected 
occurrence of sickness and disease. 
Potential participants will be asked the following questions: 
1. 
“Do you consider yourself healthy for your age?” 
 
2. 
“Are you able to participate in normal activities of daily life with respect to your age?” 
 
 
Individuals who respond affirmatively to both questions will be considered potential participants, 
and screened for any of the following exclusion criteria: 
1. 
Inability to follow age-appropriate instructions during the physical assessment 
2. 
Insufficient English to complete questionnaires 
3. 
Self-reported health conditions or factors affecting physical performance 
4. 
Presence of the following conditions: diabetes mellitus; malignant cancers; demyelinating, 
inflammatory and degenerative neurological conditions; pregnancy; class 3 obesity (BMI >40); severe 
cardiac or pulmonary disease affecting performance of daily activities; history of major surgery 
affecting physical performance; infectious or inflammatory arthropathies; severe mobility 
impairment necessitating dependence on mobility aids for all ambulation (outdoor or occasional use 
permitted) 
Due to the physical nature of most measures, the inclusion/exclusion criteria do not categorically 
exclude participants who may have mental health, cognitive or behavioural dysfunction. If potential 
participants report that they consider themselves healthy for their age and are able to participate in 
activities appropriate for their age they are then reviewed for the exclusion criteria. 
The inclusion/exclusion criteria and sampling strategy increases generalisability (external validity) of 
the Project, especially to populations considering themselves healthy for their age and will be 
relevant to multicultural/multinational populations similar to Sydney, Australia. The exclusion of 
conditions associated with altered physiological characteristics or abnormal function is necessary to 
ensure the sample reflects an appropriate level of health. The selection criteria will generate a 
reference sample that is representative of the healthy population and therefore generalisable to 
individuals who participate meaningfully in everyday life [32]. It is also necessary to ensure that the 
sample does not include only disease-free individuals, as disease and sickness are an expected 
experience of the normal ageing process. 
Generalisability (external validity) will be assessed in two ways: 
1. 
Collecting participant details related to ethnicity such as country of birth and family heritage to 
compare to other cities and countries. 
2. 
The Socio-Economic Indexes For Areas (SEIFA) indexes, a widely used measure of relative socio-
economic status of different postcode areas, providing contextual information about the area in 
which a person lives.” 
 
Procedure and setting 
Participants will attend a single appointment for assessment of physical measures, completion of 
questionnaires and collection of saliva DNA. The 1000 Norms Project Protocol Booklet, a 
comprehensive resource describing each item measured in the Project, will be used to ensure 
consistency throughout the data collection process (online supplementary Appendix B). The 
standardised procedures, verbal instructions, and scoring systems are provided for each item. Items 
have been divided into two categories: physical profile and physical performance. Physical profile 
relates to anthropometric and structural features, while physical performance examines the ability 
to carry out physical tasks. Assessments of physical performance are further categorised into seven 
constructs: dexterity, balance, ambulation, range of motion, strength and power, endurance, and 
motor planning. The individual items to be included in each of these constructs were identified by 
the 1000 Norms Project Consortium as those of most interest, and demonstrated sufficient reliability 
and construct validity to represent the construct being examined (Table 2). 
 
All assessments will be conducted by experienced physiotherapists, either M.J.M. or J.N.B., in the 
Sydney Performance Laboratory, Faculty of Health Sciences, The University of Sydney. Each item will 
be performed in a standardised order to ensure consistency for comparative data analysis. 
Participants will be given short breaks throughout the assessment according to their individual 
needs. All items are intended to be completed by all participants in two to three hours and are not 
anticipated to cause physical discomfort. Participants may choose not to undertake any of the items, 
and if a particular item is judged to be beyond the capability of the participant it will not be 
attempted and no score will be recorded. Safety considerations have been incorporated into the 
protocol for each item. A pilot study of 10 participants to evaluate feasibility and reliability of the 
protocol was conducted in September 2013 and demonstrated excellent inter-rater reliability 
(interclass correlation coefficients >0.75) between the two examiners (M.J.M. and J.N.B) for all 
measures. 
 
Demographic details as well as self-reported validated measures of quality of life, lifestyle, levels of 
physical activity, work capacity, pain and knee/ankle health will be collected. Questionnaires and the 
details of the age groups to which they are administered are outlined in Table 3. Individual saliva 
DNA Kits (Norgen Biotek, Thorold, ON, Canada) will be used to collect a 2 mL saliva sample according 
to the manufacturer's protocol. General infection control precautions and standardised procedures 
will be followed during saliva collection. 
 
Data processing and statistical analysis 
Descriptive statistics will be applied to the data, creating mean values and z scores in SPSS v22 (IBM 
SPSS Statistics for Windows, Armonk, NY, USA). Comprehensive tables of mean values and standard 
deviations stratified by age and gender will be generated. A sample size of 1000 will provide precise 
estimates of normal values for age and gender groups with narrow 95% confidence intervals. Age-
specific centile charts will be developed using quantile regression analyses and 95% confidence 
intervals will be calculated about these quantiles. Correlation analyses will be used to identify 
univariate associations between items and multiple regression analyses will be used to generate 
predictive equations adjusted for age and gender. 
Missing data will not be imputed. The 1000 Norms Project has been prospectively designed to 
minimise missing data through careful data collection methods and rigorous data cross-checking. 
Whilst there is no universally accepted statistical method to cope with missing data, all missing data 
will be described to allow readers to judge the validity of the findings [33]. 
The de-identified 1000 Norms Project dataset will be released to the international community by 
March 2016 in a freely accessible, practical and publicly accessible format by Intersect Australia 
Limited, a not-for-profit company providing eResearch data storage (www.intersect.org.au). 
Discussion 
Knowledge of normal variation of healthy individuals is essential to identify deviation from normal 
and to evaluate responses to physiotherapy and other treatments. Through improving our 
understanding of the normal range of healthy variation, the 1000 Norms Project will assist outcome 
measure development and greatly contribute to future patient-centred outcomes research. Whilst 
some normative reference values exist, there is a lack of comprehensive data cataloguing the 
physical performance and functional ability of healthy individuals across the entire lifespan. This 
project will establish a freely accessible reference dataset of over 50 musculoskeletal and 
neurological measures of a healthy population aged 3 to 100 years. Data from the 1000 Norms 
Project will assist future studies in physiotherapy to more accurately define normal (and abnormal), 
and develop norm-referenced outcome measures in clinical trials and studies of natural disease 
progression. Management of chronic musculoskeletal diseases such osteoarthritis depends on 
identification of physical impairments in strength, joint movement and balance, and resulting 
activity limitations such as walking and stair-climbing. The 1000 Norms Project reference database 
will provide ‘normal’ values for these outcomes, greatly assisting in the diagnosis of physical 
impairments and guiding best-practice management and evaluation of treatment interventions. 
 
Research investigating the relationship between genetic variation and physical characteristics in 
healthy populations is limited. The 1000 Genomes Project involved the mapping of genetic variation 
from different genomes and provided insight into the degree of normal genetic variation that exists 
between healthy individuals [34]. The 1000 Norms Project will contribute to deep phenotyping 
musculoskeletal and neurological conditions and the influence of genotype on physical performance 
through the analysis of power and speed measures in participants who have been tested for the 
ACTN3 gene. Investigating the relationship between ACTN3 genotype and physical performance 
measures in healthy norms will increase our understanding of how this polymorphism might have an 
effect on muscle function and influence therapies to improve healthy ageing. 
The 1000 Norms Project will generate new information for the age-appropriate capabilities of 
healthy ‘normal’ individuals. This information is intended to aid all healthcare stakeholders: 
researchers, physiotherapists and allied health clinicians, caregivers facing health care decisions and 
health policymakers considering the value of interventions and disability supports and services. The 
1000 Norms Project will improve our understanding of normal variation and assist clinicians to 
diagnose pathology, track disease progression and evaluate response to treatment. The resulting 
database will contribute to the development and validation of age- and gender-relevant clinical trial 
outcome measures. The 1000 Norms Project Database will provide a unique collection of healthy 
normative measures to further understand musculoskeletal and neurological dysfunction and age-
related pathological changes. 
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